BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 31337951)

  • 1. Increased Expression of LAMTOR5 Predicts Poor Prognosis and Is Associated with Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma.
    Yang QC; Wu CC; Cao LY; Xiao Y; Li H; Liu B; Sun ZJ
    Int J Med Sci; 2019; 16(6):783-792. PubMed ID: 31337951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD317 Signature in Head and Neck Cancer Indicates Poor Prognosis.
    Yang LL; Wu L; Yu GT; Zhang WF; Liu B; Sun ZJ
    J Dent Res; 2018 Jul; 97(7):787-794. PubMed ID: 29486141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-1 and PD-L1 expression in HNSCC primary cancer and related lymph node metastasis - impact on clinical outcome.
    Schneider S; Kadletz L; Wiebringhaus R; Kenner L; Selzer E; Füreder T; Rajky O; Berghoff AS; Preusser M; Heiduschka G
    Histopathology; 2018 Oct; 73(4):573-584. PubMed ID: 29742291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas.
    García-Carracedo D; Villaronga MÁ; Álvarez-Teijeiro S; Hermida-Prado F; Santamaría I; Allonca E; Suárez-Fernández L; Gonzalez MV; Balbín M; Astudillo A; Martínez-Camblor P; Su GH; Rodrigo JP; García-Pedrero JM
    Oncotarget; 2016 May; 7(20):29780-93. PubMed ID: 27119232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological features and prognostic significance of treatment effect in lymph node metastasis in head and neck squamous cell carcinoma.
    Scherpelz KP; Wong AC; Lingen MW; Taxy JB; Cipriani NA
    Histopathology; 2019 Jan; 74(2):321-331. PubMed ID: 30144145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anterior gradient protein 2 expression in high grade head and neck squamous cell carcinoma correlated with cancer stem cell and epithelial mesenchymal transition.
    Ma SR; Wang WM; Huang CF; Zhang WF; Sun ZJ
    Oncotarget; 2015 Apr; 6(11):8807-21. PubMed ID: 25871396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B7-H4 expression indicates poor prognosis of oral squamous cell carcinoma.
    Wu L; Deng WW; Yu GT; Mao L; Bu LL; Ma SR; Liu B; Zhang WF; Sun ZJ
    Cancer Immunol Immunother; 2016 Sep; 65(9):1035-45. PubMed ID: 27383830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
    Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
    Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of antioxidant network proteins as novel prognostic biomarkers for head and neck cancer patients.
    Wicker CA; Takiar V; Suganya R; Arnold SM; Brill YM; Chen L; Horbinski CM; Napier D; Valentino J; Kudrimoti MR; Yu G; Izumi T
    Oral Oncol; 2020 Dec; 111():104949. PubMed ID: 32801084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUZ12 is a novel putative oncogene promoting tumorigenesis in head and neck squamous cell carcinoma.
    Wu Y; Hu H; Zhang W; Li Z; Diao P; Wang D; Zhang W; Wang Y; Yang J; Cheng J
    J Cell Mol Med; 2018 Jul; 22(7):3582-3594. PubMed ID: 29667751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Over-expression of IQGAP1 indicates poor prognosis in head and neck squamous cell carcinoma.
    Wu CC; Li H; Xiao Y; Yang LL; Chen L; Deng WW; Wu L; Zhang WF; Sun ZJ
    J Mol Histol; 2018 Aug; 49(4):389-398. PubMed ID: 29846864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of adenosine A2A receptor enhances CD8
    Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
    Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Occult Lymph Node Metastasis in Head and Neck Cancer with CD31 Vessel Quantification.
    Mermod M; Bongiovanni M; Petrova T; Goun E; Simon C; Tolstonog G; Monnier Y
    Otolaryngol Head Neck Surg; 2019 Feb; 160(2):277-283. PubMed ID: 30084319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eps8 expression is significantly lower in p16
    Nasri E; Wiesen LB; Knapik JA; Fredenburg KM
    Hum Pathol; 2018 Feb; 72():45-51. PubMed ID: 29107665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of PANoptosis-related biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma.
    Yang P; Huang G; Li Y; Yu L; Yin Z; Li Q
    Sci Rep; 2024 Apr; 14(1):9824. PubMed ID: 38684755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podoplanin expression in lymph node metastases of head and neck cancer and cancer of unknown primary patients.
    Kühn JP; Bochen F; Körner S; Schick B; Wagner M; Smola S; Berkó-Göttel B; Morris LGT; Wang J; Bozzato A; Linxweiler M
    Int J Biol Markers; 2022 Sep; 37(3):280-288. PubMed ID: 35880270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of occult lymph node metastasis in squamous cell carcinoma of the oral cavity and the oropharynx using peritumoral Prospero homeobox protein 1 lymphatic nuclear quantification.
    Mermod M; Bongiovanni M; Petrova TV; Dubikovskaya EA; Simon C; Tolstonog G; Monnier Y
    Head Neck; 2016 Sep; 38(9):1407-15. PubMed ID: 27043718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma.
    de Carvalho AC; Scapulatempo-Neto C; Maia DC; Evangelista AF; Morini MA; Carvalho AL; Vettore AL
    BMC Med; 2015 May; 13():108. PubMed ID: 25956054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
    Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
    Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma.
    Tsujikawa T; Yaguchi T; Ohmura G; Ohta S; Kobayashi A; Kawamura N; Fujita T; Nakano H; Shimada T; Takahashi T; Nakao R; Yanagisawa A; Hisa Y; Kawakami Y
    Int J Cancer; 2013 Jun; 132(12):2755-66. PubMed ID: 23180648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.